GBST Holdings Limited updates market with lower expectations

GBST Holdings Limited (ASX:GBT) may perhaps be of interest to Iress Ltd (ASX:IRE).

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

There's nothing quite like a profit downgrade to ruin your day, well apart from a profit downgrade preceded by company management dumping their own shares just a few weeks prior to announcing the downgrade.

Step forward GBST Holdings Limited (ASX: GBT), which is a technology business that recently updated the market its first half profit would be significantly down on the prior corresponding half due to delays in major client projects and increased costs. Its now ex chief executive also sold much of his substantial holding prior to the bad news apparently unaware it was in the pipeline.

The stock dropped more than 20% on the news, with earnings for the second half forecast between $12 million to $14 million. This is a wide range that suggests more uncertainty and a full year profit almost guaranteed to be substantially down on the prior year.

Despite the disappointments the company's Wealth Management division appears to be performing strongly, with its Composer platform winning clients as an administration interface for financial advisers and their clients.

However, the company's Wealth Management division appears to be performing strongly, with its Composer platform winning clients as an administration interface for financial advisers and their clients.

The UK in particular has produced many significant client wins and remains a large financial services market for GBST to grow into.

However, the Capital Markets business which services brokers and wealth managers in terms of back office functions like settlements and trade processing has not gained the traction overseas that was hoped for on the back of significant investment.

A recent client win in Asia is a positive and investors will hope it can deliver on its potential to provide middle office services to institutional banks in the region.

GBST is forecasting a return to growth in financial year 2017, although with no permanent CEO and an uncertain outlook for the rest of this financial year the business looks one for the watch list despite the big share price falls.

A better alternative?

Another technology business that has been successful in building and selling software used by some of the world's biggest banks and money managers globally is Iress Ltd (ASX: IRE).

Altogether more mature and entrenched than GBST, Iress is also coming into an attractive valuation range for a growth stock that also offers a generous dividend of nearly 5%.

Over the years Iress has also performed especially well in the UK financial services market with market-leading data feed and software products that are deeply integrated into the order routing systems of wealth management businesses.

Iress is also on the record as being keen to grow acquisitively and both it and junior rival GBST now have similar geographic footprints, with strong UK and Australian operations alongside ambitions to grow further into other overseas markets.

Iress recently acquired a UK market data business named Proquote for an amount in the region of $80 million, although it would have to cough up many multiples of that if it were to ever make an offer to swallow GBST, which is a business currently valued around $285 million.

Today Iress is selling for $9.40, which looks a reasonable entry point for long-term growth and a big yield in today's low cash rate environment.

Motley Fool contributor Tom Richardson owns shares of GBST Holdings Limited. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. The Motley Fool Australia has no position in any of the stocks mentioned.   We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »